Ian Goodwin | Associate Director, Global Program Design
Fujifilm Diosynth Biotechnologies

Ian Goodwin, Associate Director, Global Program Design, Fujifilm Diosynth Biotechnologies

Ian Goodwin is Associate Director in the Global Program Design team at FUJIFILM Diosynth Biotechnology (FDB), based in College Station, Texas. He has been at FDB for three years, having also served as Associate Principal Scientist in the Process Development group. Ian is currently responsible for providing technical and project scope development support to prospective clients engaged in CDMO selection for viral and non-viral cell & gene therapy products. Ian?s previous experience includes seven years working on the process development and manufacturing of adeno-associated virus (AAV) and lentivirus vectors (LV) in both academic and commercial start-up environments. Ian holds a Master?s Degree in Microbiology and Immunology from Drexel University College of Medicine and a B.Sc in Microbiology from The University of Pittsburgh.


Day 2: Thursday 20th May 2021 - Gene Therapy @ 15:30

Development of a Manufacturing Platform Process for Multiple AAV Gene Therapy Vectors

  • Leveraging platform based approaches to accelerate the development of cGMP compliant processes for manufacturing viral gene therapy products from pre-clinical stages to the clinic
  • Establishment of a comprehensive, end-to-end service offering, including HEK293 suspension master cell bank, cGMP plasmid process development and manufacturing capabilities, and drug substance / drug product manufacture
  • Flexible approaches to producing other viral vectors to support cell & gene therapy and vaccine products
last published: 10/May/21 08:45 GMT

back to speakers